July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

July 02, 2025

Social Media Fuels Confusion Around Vasectomy Trends

A new review highlights how social media is shaping perceptions of vasectomy, with persistent misinformation, cultural stigma, and rising demand in the wake of the Dobbs ruling influencing men’s health decisions.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 26, 2025

Testosterone, Sleep Duration Linked to Psoriasis Risk

Low testosterone and insufficient sleep were both linked to higher odds of psoriasis in a U.S. population study, even after adjusting for age, BMI, and other factors.

Conexiant

June 25, 2025

Ultrasound Finds Early Insulin Resistance Signals

A handheld ultrasound probe could soon help detect metabolic issues long before blood sugar levels raise concerns.

Conexiant

June 25, 2025

Combo Obesity Therapy Preserves Muscle, Reduces Fat

A new combination therapy of semaglutide and bimagrumab helped patients lose more fat while preserving muscle mass, while a novel biosensor may help track muscle loss during obesity treatment.

Conexiant

June 24, 2025

HSV-1 Restructures Human Genome via Hijacking

Researchers uncovered how herpes simplex virus type 1 reprograms human chromatin structure by hijacking transcriptional machinery, potentially revealing a new antiviral target.

Conexiant